Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
WOOJUNG BIO, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩2,125.00 |
52 Week High | ₩4,125.00 |
52 Week Low | ₩1,100.00 |
Beta | 0.63 |
11 Month Change | 43.19% |
3 Month Change | 36.13% |
1 Year Change | -19.66% |
33 Year Change | -67.31% |
5 Year Change | -60.35% |
Change since IPO | -62.96% |
Recent News & Updates
WOOJUNG BIO, Inc.'s (KOSDAQ:215380) Shares Bounce 43% But Its Business Still Trails The Industry
Aug 16Revenues Working Against WOOJUNG BIO, Inc.'s (KOSDAQ:215380) Share Price Following 26% Dive
Jun 14Is WOOJUNG BIO (KOSDAQ:215380) Weighed On By Its Debt Load?
May 23Shareholder Returns
A215380 | KR Life Sciences | KR Market | |
---|---|---|---|
7D | 31.1% | -2.6% | 4.1% |
1Y | -19.7% | 23.8% | 5.2% |
Return vs Industry: A215380 underperformed the KR Life Sciences industry which returned 23.7% over the past year.
Return vs Market: A215380 underperformed the KR Market which returned 2.5% over the past year.
Price Volatility
A215380 volatility | |
---|---|
A215380 Average Weekly Movement | 12.4% |
Life Sciences Industry Average Movement | 8.8% |
Market Average Movement | 6.5% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A215380's share price has been volatile over the past 3 months.
Volatility Over Time: A215380's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1989 | n/a | n/a | www.woojungbsc.co.kr |
WOOJUNG BIO, Inc. provides research and laboratory services in Korea. The company offers environmental infection control. It also provides construction solutions, such as preventing clean and infected; hospital negative pressure isolation ward; pharmaceutical company's aseptic production rooms; general and animal laboratory; high-risk pathogen research facility; and HEPA box air conditioning systems.
WOOJUNG BIO, Inc. Fundamentals Summary
A215380 fundamental statistics | |
---|---|
Market cap | ₩31.57b |
Earnings (TTM) | -₩2.82b |
Revenue (TTM) | ₩40.67b |
0.8x
P/S Ratio-11.2x
P/E RatioIs A215380 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A215380 income statement (TTM) | |
---|---|
Revenue | ₩40.67b |
Cost of Revenue | ₩33.27b |
Gross Profit | ₩7.40b |
Other Expenses | ₩10.22b |
Earnings | -₩2.82b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -189.91 |
Gross Margin | 18.19% |
Net Profit Margin | -6.94% |
Debt/Equity Ratio | 232.1% |
How did A215380 perform over the long term?
See historical performance and comparison